CSA2017 中华医学会第25 次全国麻醉学术年会 2017 郑州 25th Annual Meeting of the Chinese Society of Anaesthesiology

25th Annual Meeting of the Chinese Society of Anaesthesiology

Almost 10,000 doctors from China joining together to learn about the latest developments in anaesthesiology. Impressions of the 25th Annual Meeting of the Chinese Society of Anaesthesiology - CSA2017 - 中华医学会第25 次全国麻醉学术年会

Pharma Digital Marketing: Lackluster or Blockbuster?

Pharma Digital Marketing: Lackluster or Blockbuster?

adjuvant hormonal therapy

Should all Women with Endocrine-Sensitive and Operable Breast Cancer Receive Adjuvant Hormonal Therapy?

Should all Women with Endocrine-Sensitive and Operable Breast Cancer Receive Adjuvant Hormonal Therapy?

esmo 2016 breast cancer ribociclib palbociclib abemaciclib data medipaper medicall writer

#ESMO16 #BreastCancer: #Palbociclib, #Ribociclib and #Abemaciclib Data #Ibrance #Pfizer #Novartis #Lilly

ESMO 2016 Breast Cancer: Focus on CDK4/6

2016 pancreatic cancer awareness month IMM-101 plus Gemcitabine medipaper medical communications medical writer hire healthcare writers hong kong

Do you know your lifetime risk on #PancreaticCancer? #November is #PancreaticCancerAwarenessMonth. #oncology #cancer

Pancreatic Cancer Awareness Month: What is your Risk?

immunotherapies cancer patient medipaper medical communications hire healthcare writers hong kong medical writing services 香港醫學作家

#Immunotherapy & #Cancer: What to Expect as #Patient? #ImmunoOncology #ImmuneCheckpoint #ESMO16

Immunotherapies in cancer: What to Expect as patient

Biomarkers Ipilimumab Treatment MediPaper Medical Communications

Novel #Biomarker for #Ipilimumab Treatment may aid Future #Patient Selection in Several #Malignancies #CISC

Novel Biomarker for Ipilimumab Treatment

ESMO 2016 ipilimumab data medipaper medical communications

#ESMO16 #Ipilimumab data - Download the PPT! #immunooncolgy #ESMO2016 #Yervoy #Melanoma #BMS #Skincancer

ESMO 2016 Ipilimumab (Yervoy®) Data

ESMO 2016 pembrolizumab data medipaper medical communications

#ESMO16 #Pembrolizumab data - Download the PPT! #ESMO2016 #NSCLC #melanoma #Merck #Keytruda

ESMO 2016 Pembrolizumab (Keytruda®) Data

ESMO 2016 durvalumab avelumab tremelimumab data medipaper medical communications

#ESMO16 #Durvalumab #Avelumab #Tremelimumab Data- Download the PPT! #ImmunoOncology #ESMO2016 #ImmuneCheckpoint

ESMO 2016 Durvalumab, Avelumab, and Tremelimumab Data

ESMO 2016 atezolizumab data medipaper medical communications

#ESMO16 #Atezolizumab data - Download the PPT! #immunooncology #ESMO2016 #Roche #NSCLC #mUCC

ESMO 2016 Atezolizumab (Tecentriq®)

ESMO 2016 nivolumab data medipaper medical communications

#ESMO16 #Nivolumab data - Download the PPT! #immunooncology #ESMO2016 #NSCLC #Skincancer #BMS

ESMO 2016 Nivolumab (Opdivo®) Data

esmo 2016 immunotherapy track medipaper medi-paper-com medical communications

#MediPaper is following the #ESMO2016 #Immunotherapy Track. Sign up for our #newsletter and get notified. #ESMO16 #immunooncology

MediPaper is following the ESMO 2016 Immunotherapy Track. Sign up for our newsletter and get notified

cancer awareness improves outcome medipaper medical communications

#Cancer #symptom #awareness linked to #survival #oncology #bjc #nature #esmo16

CRUK: Cancer Symptom Awareness linked to Survival

2016 ASCO ovarian cancer guidelines neo-adjuvant chemotherapy medipaper medical communications

#ASCO #Guideline #NeoAdjuvant #CTx for #OvarianCancer Updated #MoonShots #ESMO16

2016 ASCO Ovarian Cancer Guidelines for Neo-Adjuvant Chemotherapy

IMM-101 plus gemcitabine-medipaper medical communications BW

#IMM101 plus #Gemcitabine Hopeful in #Metastatic #PancreaticCancer

IMM-101 Plus Gemcitabine in Metastatic Pancreatic Cancer

ASCO 2016 Durvalumab & Tremelimumab Data - MediPaper Medical Communications

Remember our #ASCO16 #Tremelimumab and #Durvalumab data summary #PPT? Stay tuned for #ESMO16 #immunooncology

Remember our ASCO16 Tremelimumab data summary PowerPoint slides?

ASCO 2016 Durvalumab & Tremelimumab Data - MediPaper Medical Communications

Remember our #ASCO16 #Durvalumab and #Tremelimumab data summary #PPT? Stay tuned for #ESMO16 #immunooncology

Remember our ASCO16 Durvalumab data summary PowerPoint slides?

ASCO2016 Avelumab Data - MediPaper Medical Communications

Remember our #ASCO16 #Avelumab data summary #PowerPoint? Stay tuned for #ESMO16 #skincancer #Moonshots

Remember our ASCO16 Avelumab data summary PowerPoint slides?

ASCO2016 Ipilimumab Data - MediPaper Medical Communications

Remember our #ASCO16 #Ipilimumab data summary #PowerPoint? Stay tuned for #ESMO16 #melanoma #skincancer

Remember our ASCO16 Ipilimumab data summary PowerPoint slides?

ASCO 2016 Atezolizumab Data

Remember our #ASCO16 #Atezolizumab data summary #PowerPoint? Stay tuned for #ESMO16 #oncology

Remember our ASCO16 Atezolizumab data summary PowerPoint slides?

ASCO2016 Pembrolizumab Data - MediPaper Medical Communications

Remember our #ASCO16 #Pembrolizumab data summary #PowerPoint? Stay tuned for #ESMO16 #moonshots

Remember our ASCO16 Pembrolizumab data summary PowerPoint slides?

ASCO2016-Nivolumab-Data - MediPaper Medical Communications

Remember our #ASCO16 #Nivolumab data summary #PowerPoint? Stay tuned for #ESMO16 #immunotherapy

Remember our ASCO16 Nivolumab data summary PowerPoint slides?

medical-blog-SEO-optimisation

#MedicalBlog #SEO Optimisation #bigpharma #oncology #diabetes #immunecheckpoint #immunooncology

MediPaper: Medical Blog SEO Optimisation

ASCO 2016 ribociclib & abemaciclib Data - MediPaper Medical Communications

#ASCO16 #Ribociclib & #Abemaciclib Data #NovartisCancer #Lilly #BreastCancer #luminalbc #CDK46 #ESMO16

ASCO 2016 Ribociclib & Abemaciclib Data

ASCO 2016 Palbociclib Data MediPaper Medical Communications

#ASCO16 #palbociclib (#Ibrance) Data #Pfizer #BreastCancer #luminalbc #CDK46 #ESMO16

ASCO 2016 Palbociclib (Ibrance™) Data

ASCO 2016 Avelumab Durvalumab and Tremelimumab Data - MediPaper Medical Communications

#ASCO16 #Avelumab, #Durvalumab and #Tremelimumab #Pfizer @Astrazeneca #ImmunoOncology #ImmuneCheckpoint

ASCO2016 Avelumab, Durvalumab and Tremelimumab

asco 2016 atezolizumab data

#ASCO16 #Atezolizumab (#Tecentriq) Data @Roche #ImmunoOncology #ImmuneCheckpoint #BladderCancer

ASCO 2016 Atezolizumab (Tecentriq™) Data

ASCO2016 ipilimumab data - MediPaper Medical Communications

#ASCO16 #Ipilimumab (#Yervoy) Data @BMS #ImmunoOncology #ImmuneCheckpoint #Melanoma

ASCO 2016 Ipilimumab (Yervoy™) Data

asco 2016 nivolumab medipaper medical communications

#ASCO16 #Nivolumab (#Opdivo) Data #BMS #ImmunoOncology #ImmuneCheckpoint #NSCLC

ASCO 2016 Nivolumab (OPDIVO™) Data